Sarangi A, Salem M, Younus M, El-Haroun H, Mahal A, Tripathy L
Int J Surg. 2024; 110(12):7508-7527.
PMID: 39411890
PMC: 11634172.
DOI: 10.1097/JS9.0000000000002110.
Vica M, Dobreanu M, Curocichin G, Matei H, Balici S, Vuscan M
Int J Mol Sci. 2024; 25(2).
PMID: 38279325
PMC: 10816224.
DOI: 10.3390/ijms25021326.
Mota G, Marques C, Ribeiro S, Albuquerque C, Castro G, Fernandino D
Adv Rheumatol. 2023; 63(1):56.
PMID: 38031143
DOI: 10.1186/s42358-023-00340-0.
Shapiro J, Roberts C, Arcovio K, Reade L, Klein S, Dhakal S
Curr Top Microbiol Immunol. 2023; 441:75-110.
PMID: 37695426
DOI: 10.1007/978-3-031-35139-6_4.
Biancolella M, Colona V, Luzzatto L, Watt J, Mattiuz G, Conticello S
Hum Genomics. 2023; 17(1):68.
PMID: 37488607
PMC: 10367267.
DOI: 10.1186/s40246-023-00515-2.
Molecular Understanding of ACE-2 and HLA-Conferred Differential Susceptibility to COVID-19: Host-Directed Insights Opening New Windows in COVID-19 Therapeutics.
Ul Haq I, Krukiewicz K, Tayyab H, Khan I, Khan M, Yahya G
J Clin Med. 2023; 12(7).
PMID: 37048725
PMC: 10095019.
DOI: 10.3390/jcm12072645.
Effect of probiotics as an immune modulator for the management of COVID-19.
Ray M, Manjunath A, Halami P
Arch Microbiol. 2023; 205(5):182.
PMID: 37031431
PMC: 10098245.
DOI: 10.1007/s00203-023-03504-0.
Targeted capture enrichment and sequencing identifies HLA variants associated with the severity of COVID-19.
Liu C, Zhang L, Chen J, Gao Y
Genes Genomics. 2022; 45(4):451-456.
PMID: 36574143
PMC: 9793816.
DOI: 10.1007/s13258-022-01358-2.
Exome-Wide Association Study Reveals Host Genetic Variants Likely Associated with the Severity of COVID-19 in Patients of European Ancestry.
Upadhyai P, Shenoy P, Banjan B, Albeshr M, Mahboob S, Manzoor I
Life (Basel). 2022; 12(9).
PMID: 36143338
PMC: 9504138.
DOI: 10.3390/life12091300.
Clinical implications of host genetic variation and susceptibility to severe or critical COVID-19.
van der Made C, Netea M, van der Veerdonk F, Hoischen A
Genome Med. 2022; 14(1):96.
PMID: 35986347
PMC: 9390103.
DOI: 10.1186/s13073-022-01100-3.
Virology of SARS-CoV-2 and management of nCOVID-19 utilizing immunomodulation properties of human mesenchymal stem cells-a literature review.
Sachdeva K, Kumar A, Mohanty S
Stem Cell Investig. 2021; 8:23.
PMID: 34917676
PMC: 8642741.
DOI: 10.21037/sci-2020-040.
Association of HLA class I and II genes with Middle East respiratory syndrome coronavirus infection in Koreans.
Baek I, Choi E, Shin D, Kim H, Choi H, Shin H
Immun Inflamm Dis. 2021; 10(1):111-116.
PMID: 34637605
PMC: 8669699.
DOI: 10.1002/iid3.541.
Molecular Insights into the Crosstalk Between Immune Inflammation Nexus and SARS-CoV-2 Virus.
Bose P, Sunita P, Pattanayak S
Curr Microbiol. 2021; 78(11):3813-3828.
PMID: 34550435
PMC: 8456397.
DOI: 10.1007/s00284-021-02657-9.
Comparative Analysis of Susceptibility and Severity of COVID-19 in Countries from the Eastern and the Western World Till March '21.
Chawla S, Chawla S
Microbiol Insights. 2021; 14:11786361211041367.
PMID: 34483666
PMC: 8411631.
DOI: 10.1177/11786361211041367.
Association between HLA genotypes and COVID-19 susceptibility, severity and progression: a comprehensive review of the literature.
Migliorini F, Torsiello E, Spiezia F, Oliva F, Tingart M, Maffulli N
Eur J Med Res. 2021; 26(1):84.
PMID: 34344463
PMC: 8329616.
DOI: 10.1186/s40001-021-00563-1.
The COVID-19 pandemic: an increased risk of rheumatoid arthritis.
Tripathy A, Swain N, Gupta B
Future Virol. 2021; .
PMID: 34181704
PMC: 8221023.
DOI: 10.2217/fvl-2020-0393.
HLA-A homozygosis is associated with susceptibility to COVID-19.
de Marco R, Faria T, Mine K, Cristelli M, Medina-Pestana J, Tedesco-Silva H
HLA. 2021; 98(2):122-131.
PMID: 34165257
PMC: 8446943.
DOI: 10.1111/tan.14349.
Antigen presentation in SARS-CoV-2 infection: the role of class I HLA and ERAP polymorphisms.
Saulle I, Vicentini C, Clerici M, Biasin M
Hum Immunol. 2021; 82(8):551-560.
PMID: 34116863
PMC: 8108382.
DOI: 10.1016/j.humimm.2021.05.003.
Innate and Adaptive Immune Genes Associated with MERS-CoV Infection in Dromedaries.
Lado S, Elbers J, Plasil M, Loney T, Weidinger P, Camp J
Cells. 2021; 10(6).
PMID: 34070971
PMC: 8224694.
DOI: 10.3390/cells10061291.
MHC Haplotyping of SARS-CoV-2 Patients: HLA Subtypes Are Not Associated with the Presence and Severity of COVID-19 in the Israeli Population.
Ben Shachar S, Barda N, Manor S, Israeli S, Dagan N, Carmi S
J Clin Immunol. 2021; 41(6):1154-1161.
PMID: 34050837
PMC: 8164405.
DOI: 10.1007/s10875-021-01071-x.